Chemical Industry: 100% (2025)

Top 3 Markets:

1. Pharmaceutical Industry: approximately 70%
2. Agricultural Chemicals: approximately 20%
3. Specialty Chemicals: approximately 10%

Dottikon ES Holding AG generates the majority of its revenue from the chemical industry, with the pharmaceutical industry accounting for the largest share. This is due to the company's specialization in the production of active ingredients and intermediates for the pharmaceutical industry.

Agricultural chemicals and specialty chemicals also contribute to the revenues, but to a lesser extent. This diversification allows Dottikon to benefit from different market segments and spread risks.

Production Site: Dottikon, Switzerland

Dottikon ES Holding AG mainly produces its products in Dottikon, Switzerland. The site is known for its specialization in chemical processes and the production of fine chemicals. The company specializes in the production of high-quality chemical intermediates and active ingredients, using state-of-the-art technologies and processes. The Dottikon site offers strategic advantages due to its central location in Europe and its proximity to key markets.

Strategy for Future Growth: Diversification and Capacity Expansion

Dottikon ES Holding AG pursues a strategy of diversification and capacity expansion to secure future growth. In recent years, the company has increasingly invested in expanding its production capacities to meet the growing demand for specialized chemical products.

Another focus is on developing new technologies and expanding the product portfolio, especially in the pharmaceutical and fine chemicals sector. Through these measures, Dottikon ES aims to strengthen its market position and tap into new business areas.

Additionally, the company relies on strategic partnerships and collaborations to gain access to new markets and leverage synergies that can further promote growth.

Main raw materials: Chemical raw materials, solvents

Countries of origin: Germany, China, USA

Dottikon ES Holding AG is a specialist in the production of chemical intermediates and fine chemicals. The company mainly imports chemical raw materials and solvents that are essential for their production processes.

Germany is an important supplier due to the high quality and proximity, which facilitates logistics. China plays a significant role due to the cost-effective production of basic chemicals. The USA is also a key partner, especially for specialized chemical components needed in production.

This diversification of suppliers enables Dottikon to source both high-quality and cost-effective raw materials, which is crucial for their competitiveness.

Revenue growth: 8.5% (2024)
EBITDA margin: 25% (2024)
Market share in specialty chemicals: 5% (estimated, 2024)

Dottikon ES Holding AG is a leading company in the field of specialty chemicals, particularly in the production of active ingredients and intermediates for the pharmaceutical industry. The company's competitive advantage lies in its strong focus on safety and quality, which is crucial in the industry.

The company benefits from high customer loyalty and long-term contracts with major pharmaceutical companies. These strategic partnerships secure stable revenues and enable Dottikon to continuously invest in research and development to offer innovative solutions.

Another advantage is the geographical location in Switzerland, known for its strict regulatory standards, which builds trust among international customers. Despite an intense competitive environment, Dottikon can maintain a solid competitive advantage through its specialization and quality assurance.

Institutional Investor Share: approximately 40% (estimated, 2025)
Insider Purchases/Sales: No significant transactions in the last six months (2025)

The institutional investor share in Dottikon ES Holding AG is estimated to be around 40%. This reflects the interest of institutional investors in the company's stability and growth prospects.

There have been no significant insider purchases or sales in the last six months, indicating that the management has confidence in the current corporate strategy and does not expect any significant changes in ownership structure.

Market share of Dottikon ES Holding AG: Estimated 5% (2025)

Top competitors and their market share:

1. Lonza Group AG: 20%
2. Siegfried Holding AG: 15%
3. Evonik Industries AG: 10%
4. Catalent, Inc.: 8%
5. Cambrex Corporation: 7%
6. Dottikon ES Holding AG: 5%
7. Recipharm AB: 4%
8. WuXi AppTec: 3%
9. Thermo Fisher Scientific: 2%
10. Boehringer Ingelheim: 2%

Dottikon ES Holding AG is a specialized provider in the field of chemical fine and specialty chemicals production. The company's moat lies in its expertise in safety-critical chemistry and its ability to master complex chemical processes. This enables them to offer high-quality and specialized products that are not easily replicable by competitors.

Compared to larger competitors like Lonza or Siegfried, which have more extensive production capacities and a broader product portfolio, Dottikon's moat is more focused on niche markets and specialized applications. While larger companies may have a stronger financial and infrastructural advantage, Dottikon can score points through its specialization and flexibility.

Overall, Dottikon ES has a significant advantage in its niche, but the moat is limited compared to the broader capabilities and resources of larger competitors.

Revenue Growth: 8.2% (2024) EBITDA Margin: 24.5% (2024) R&D Expenses: 12% of revenue (2024)

Dottikon ES Holding AG recorded a revenue growth of 8.2% in 2024, indicating strong demand for its specialized chemical products. The EBITDA margin of 24.5% demonstrates the company's solid profitability and operational efficiency.

Another positive aspect is the high proportion of spending on research and development, amounting to 12% of revenue. This suggests that Dottikon ES is investing in innovations to strengthen its market position and secure future growth.

Overall, Dottikon ES exhibits strong financial performance and a strategic focus on innovation, making it a potentially attractive investment. However, investors should also consider macroeconomic factors and industry-specific risks.

Dividend: 0.00 CHF (2025)

Dottikon ES Holding AG has not paid any dividends in recent years, which is also the case in 2025. The company traditionally pursues a policy of retaining earnings to use the funds for investments and growth.

This strategy allows Dottikon to react flexibly to market changes and to invest in the further development of its technologies and capacities. Therefore, the reliability of dividend payments is not guaranteed, as the company does not make regular dividend payments.